🇺🇸 FDA
Pipeline program

Placebo matching REGN7508, REGN7508

R7508-CAT-2392

Phase 3 small_molecule active

Quick answer

Placebo matching REGN7508, REGN7508 for Cancer-Associated Thrombosis (CAT). is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Cancer-Associated Thrombosis (CAT).
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials